Cargando…
Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patients
In glioblastoma multiforme (GBM), both temozolomide (TMZ) and cisplatin are very active at various toxic levels. Previous studies demonstrated that cisplatin with the standard regimen of TMZ is active in patients suffering from recurrent GBM, generating a moderate level of toxicity. Also, continuous...
Autores principales: | Wang, Yu, Kong, Xiangyi, Guo, Yi, Wang, Renzhi, Ma, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348180/ https://www.ncbi.nlm.nih.gov/pubmed/28272232 http://dx.doi.org/10.1097/MD.0000000000006261 |
Ejemplares similares
-
Targeted next-generation sequencing of malignant peripheral nerve sheath tumor of the pterygopalatine fossa with intracranial metastatic recurrence
por: Bao, Xinjie, et al.
Publicado: (2018) -
Glioblastoma multiforme in conus medullaris with intracranial metastasis after postoperative adjuvant therapy
por: Yan, Chengrui, et al.
Publicado: (2017) -
Apatinib combined with temozolomide treatment for pseudoprogression in glioblastoma: A case report
por: Zhao, Mingming, et al.
Publicado: (2022) -
Survival analysis of patients with glioblastoma treated by long-term administration of temozolomide
por: Quan, Rencui, et al.
Publicado: (2020) -
Dysphasia and Phantosmia as First Presentation of Multifocal Cerebral Anaplastic Astrocytomas: Case Report and Review of the Literatures
por: Kong, Xiangyi, et al.
Publicado: (2015)